Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 34B (ANKRD34B) is a protein encoded by the human ANKRD34B gene, with the canonical UniProt ID A5PLL1. It is part of a broad family of proteins defined by the presence of ankyrin repeat motifs, which serve as common protein–protein interaction scaffolds in diverse cellular processes. The ankyrin repeat is a structural motif that mediates specific binding surfaces for molecular recognition, but ANKRD34B itself does not have a well-established, unique molecular function or enzyme activity. Bioinformatic predictions suggest its localization to the cytoplasm and nucleus, perhaps associated with structures like pi-bodies. There is a single, weak disease association (neonatal candidiasis), but the evidence is limited and does not support a therapeutic role. ANKRD34B is not currently the subject of approved or investigational drugs, nor is it used as a diagnostic or predictive biomarker. Its role, if any, in disease remains to be thoroughly characterized. - ANKRD34B is a non-enzymatic, non-receptor protein characterized by ankyrin repeat domains that likely function in general protein scaffolding and interactions, with no established direct therapeutic relevance. - There is no evidence for it being a current or emerging therapeutic target, no known small molecule modulators, and no notable safety concerns or biomarker utility.
Not applicable; this is not presently a therapeutic target, and there are no drugs known to act via this protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 34B (ANKRD34B).